714
S. MORI et al.
stirred at room temperature for 16 h before addition of
ether. After filtration, the filtrate was concentrated. The
residue was applied to silica gel column chromatography
(2% EtOAc/hexane) to give ketone 4 (41.9 g, 0.11 mol,
(CHCl3): 2932, 1782, 1701, 1387, 1246, 1111, 1036,
909 cmꢁ1. Anal. Found: C, 70.33; H, 8.05; N, 2.20.
Calcd. for C36H47O6NSi: C, 69.97; H, 7.67; N, 2.27%.
20
(S)-[(S)]-7, ½ꢀꢂ
¼ þ27 (c 2.9, CHCl3).
D
73%) as a colorless oil. NMR spectra were agreed
20
with that of literature.4) ½ꢀꢂ
¼ þ0:8 (c 2.4, CHCl3),
(R)-4-Benzyl-3-[(2R,6R)-8-(tert-butyldiphenylsilyloxy)-
2-hydroxy-6-(methoxymethoxy)octanoyl]-2-oxazolidinone
(8). To a solution of KHMDS (72.6 ml, 0.5 M in toluene,
36.3 mmol) in THF (150 ml) was added a solution of
acyl oxazolidinone 7 (15.0 g, 24.2 mmol) in THF
(100 ml). After the mixture was stirred at ꢁ75 ꢀC for
30 min, MoOPH (15.8 g, 36.4 mmol) was added. The
reaction mixture was stirred at ꢁ75 ꢀC for 2 h, and then
sat. aq. Na2SO3 solution and EtOAc were added. The
organic solution was separated, washed with 1 M aq. HCl
solution, sat. aq. NaHCO3 solution, and brine, and dried
(Na2SO4). Concentration followed by silica gel column
chromatography (EtOAc/toluene ¼ 1=9) gave alcohol 8
(8.11 g, 12.8 mmol, 53%) as a colorless oil. Acyl
D
20
½ꢀꢂ
¼ ꢁ0:9 (c 3.3, CHCl3) in the literature.4)
D
(R)-8-(tert-Butyldiphenylsilyloxy)-6-(methoxymethoxy)-
octanoic acid (6). A reaction solution of ester 5 (23.3 g,
49.3 mmol) in EtOH (200 ml) and 6 M aq. KOH solution
(200 ml) was stirred at 0 ꢀC for 1 h before addition of
CHCl3. After acidification with 6 M aq. HCl solution, the
organic solution was separated, washed with brine, and
dried (Na2SO4). Concentration followed by silica gel
column chromatography (EtOAc/hexane ¼ 1=2) gave
carboxylic acid 6 (22.0 g, 48.0 mmol, 97%) as a color-
20
less oil. ½ꢀꢂ
¼ ꢁ1:6 (c 1.9, CHCl3). NMR ꢁH
D
(CDCl3): 1.05 (9H, s, tert-Bu), 1.39 (2H, m), 1.51
(2H, m), 1.63 (2H, m), 1.73 (2H, m), 2.34 (2H, t, J
7.3 Hz, 2-H2), 3.31 (3H, s, OCH2OCH3), 3.73–3.77 (3H,
m, 6-H, 8-H2), 4.58 (1H, d, J 6.8 Hz, OCHHOMe), 4.61
(1H, d, J 6.8 Hz, OCHHOMe), 7.36–7.42 (6H, m, ArH),
7.64–7.67 (4H, m, ArH). NMR ꢁC (CDCl3): 19.2, 24.7,
24.8, 26.9, 33.9, 34.4, 37.3, 55.5, 60.6, 74.7, 95.7, 127.6,
129.6, 133.9, 135.6, 179.0. IR ꢂmax (CHCl3): 2934,
1709, 1111, 1036, 909 cmꢁ1. Anal. Found: C, 68.18; H,
oxazolidinone 7 (3.74 g, 6.05 mmol, 26%) was recov-
20
ered. ½ꢀꢂ
¼ ꢁ31 (c 1.8, CHCl3). NMR ꢁH (CDCl3):
D
1.05 (9H, s, tert-Bu), 1.49–1.62 (5H, m), 1.72–1.85 (3H,
m), 2.84 (1H, dd, J 13.4, 9.5 Hz, ArCHH), 3.30 (1H, dd,
J 13.4, 3.4 Hz, ArCHH), 3.31 (3H, s, OCH2OCH3), 3.46
(1H, d, J 7.8 Hz, OH), 3.70–3.80 (3H, m, CHOMOM,
CH2OTBDPS), 4.23–4.27 (2H, m, 5-H2), 4.58 (1H, d, J
6.8 Hz, OCHHOMe), 4.61 (1H, d, J 6.8 Hz, OCH-
HOMe), 4.65 (1H, m, 4-H), 4.97 (1H, m, CHOH), 7.18–
7.21 (3H, m, ArH), 7.25–7.41 (8H, m, ArH), 7.64–7.67
(4H, m, ArH). NMR ꢁC (CDCl3): 19.2, 21.0, 26.9, 34.2,
34.4, 37.4, 37.5, 55.48, 55.50, 60.6, 66.9, 70.7, 74.7,
95.8, 127.50, 127.61, 129.0, 129.4, 129.6, 133.9, 134.8,
135.5, 153.2, 174.9. IR ꢂmax (CHCl3): 3530, 1788, 1694,
1389, 1352, 1298, 1113, 1036, 911 cmꢁ1. Anal. Found:
87.54. Calcd. for C26H38O5Si: C, 68.09; H, 8.35%. (S)-6,
20
½ꢀꢂ
¼ þ1:6 (c 1.2, CHCl3).
D
(R)-4-Benzyl-3-[(R)-8-(tert-butyldiphenylsilyloxy)-6-
(methoxymethoxy)octanoyl]-2-oxazolidinone (7). To a
solution of carboxylic acid 6 (10.2 g, 22.2 mmol) in THF
(200 ml) was added Et3N (3.25 ml, 2.36 g, 23.3 mmol)
and PivCl (2.87 ml, 2.81 g, 23.3 mmol) at ꢁ75 ꢀC, and
then the resulting mixture was stirred at 0 ꢀC for 1 h
before cooling to ꢁ75 ꢀC. To the resulting mixture was
added a solution of lithium salt of (R)-4-benzyl-2-
oxazolidinone (4.13 g, 23.3 mmol) in THF (100 ml) at
ꢁ75 ꢀC. After the resulting reaction mixture was stirred
at 0 ꢀC for 1 h, sat. aq. NH4Cl solution was added. The
organic solution was separated, washed with brine, and
dried (Na2SO4). Concentration followed by silica gel
column chromatography (EtOAc/hexane ¼ 1=4) gave
C, 68.46; H, 7.95; N, 2.21. Calcd. for C36H47O7NSi: C,
20
68.22; H, 7.47; N, 2.21%. (S)-[(2S,6S)]-8, ½ꢀꢂ
¼ þ31
D
(c 1.2, CHCl3).
(2R,6R)-8-(tert-Butyldiphenylsilyloxy)-6-(methoxyme-
thoxy)-1,2-octanediol (9). To an ice-cooled solution of
acyl oxazolidinone 8 (7.04 g, 11.1 mmol) and MeOH
(1.80 ml, 44.4 mmol) in THF (50 ml) was added LiBH4
(1.21 g, 55.6 mmol). The reaction solution was stirred at
0 ꢀC for 2 h before additions of sat. aq. NH4Cl solution
and EtOAc. The organic solution was separated, washed
with brine, and dried (Na2SO4). Concentration followed
by silica gel column chromatography (EtOAc/hexane ¼
acyl oxazolidinone 7 (13.0 g, 21.0 mmol, 95%) as a
20
colorless oil. ½ꢀꢂ
¼ ꢁ27 (c 1.9, CHCl3). NMR ꢁH
D
(CDCl3): 1.05 (9H, s, tert-Bu), 1.41–1.47 (2H, m), 1.55
(2H, m), 1.65–1.77 (2H, m), 1.74 (2H, m), 2.76 (1H, dd,
J 13.4, 9.5 Hz, ArCHH), 2.86–3.02 (2H, m, CH2C=O),
3.30 (1H, dd, J 13.4, 2.9 Hz, ArCHH), 3.31 (3H, s,
OCH2OCH3), 3.73–3.81 (3H, m, CHOMOM,
CH2OTBDPS), 4.11–4.21 (2H, m, 5-H2), 4.59 (1H, d,
J 6.8 Hz, OCHHOMe), 4.62 (1H, d, J 6.8 Hz, OCH-
HOMe), 4.67 (1H, m, 4-H), 7.19–7.21 (3H, m, ArH),
7.25–7.43 (8H, m, ArH), 7.65–7.68 (4H, m, ArH). NMR
ꢁC (CDCl3): 19.1, 24.4, 24.8, 26.8, 34.5, 35.5, 37.4, 37.9,
55.1, 55.5, 60.6, 66.1, 74.7, 95.7, 127.3, 127.6, 128.9,
129.4, 129.6, 133.9, 135.3, 135.5, 153.4, 173.1. IR ꢂmax
2=1) gave glycol 9 (4.57 g, 9.92 mmol, 89%) as a
20
colorless oil. ½ꢀꢂ
¼ þ2:8 (c 1.8, CHCl3). NMR ꢁH
D
(CDCl3): 1.05 (9H, s, tert-Bu), 1.42–1.52 (6H, m), 1.73
(2H, m), 2.22 (1H, br. s, OH), 2.41 (1H, br. s, OH), 3.31
(3H, s, OCH2OCH3), 3.42 (1H, dd, J 10.7, 7.8 Hz, 1-
HH), 3.66 (1H, dd, J 10.7, 11.2 Hz, 1-HH), 3.70 (1H, m,
2-H), 3.71–3.79 (3H, m, 6-H, 8-H2), 4.59 (1H, d, J
6.6 Hz, OCHHOMe), 4.62 (1H, d, J 6.6 Hz, OCH-
HOMe), 7.36–7.44 (6H, m, ArH), 7.64–7.67 (4H, m,
ArH). NMR ꢁC (CDCl3): 19.2, 21.2, 26.8, 33.1, 34.6,
37.4, 55.5, 60.5, 66.8, 72.0, 74.9, 95.8, 127.6, 129.6,